Jillian Tsai, Lead of Palliative Radiotherapy and Oligometastases Program (PROP) at Princess Margaret Cancer Centre, posted on X:
“Honored to join the discussion on biology-directed RT for MBC.
Global Breast Cancer Conference Korea – great exchange on trial design frameworks and upcoming studies incl. AVATAR2 (Trans Tasman Radiation Oncology Group), Clarity (NRG Oncology), and S2511 (SWOG).
Time to push forward a dedicated trial for TNBC?”
Other articles featuring Jillian Tsai on OncoDaily.
